SILENCING M 6 A READER YTHDC1 REDUCES INFLAMMATORY RESPONSE IN SEPSIS-INDUCED CARDIOMYOPATHY BY INHIBITING SERPINA3N

Wenjing Xie1, Anqi Zhang, Xuliang Huang

  • 1Department of Anesthesia, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Shock (Augusta, Ga.)
|March 6, 2023
PubMed

Insights

The m6A reader YTHDC1 regulates SERPINA3N mRNA, reducing inflammation and improving cardiac function in sepsis-induced cardiomyopathy. This finding offers new therapeutic insights for sepsis complications.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Immunology

Background:

  • Sepsis-induced cardiomyopathy (SIC) is a common sepsis complication driven by inflammatory mediator imbalance.
  • N6-methyladenosine (m6A) modification is implicated in sepsis development.
  • The role of the m6A reader YTHDC1 in SIC is currently unknown.

Purpose of the Study:

  • To investigate the role of YTHDC1 in sepsis-induced cardiomyopathy.
  • To explore the regulatory relationship between YTHDC1 and SERPINA3N in SIC.

Main Methods:

  • Utilized a lipopolysaccharide (LPS)-induced mouse model of SIC.
  • Employed YTHDC1-shRNA and SERPINA3N-siRNA for knockdown experiments.
  • Analyzed Gene Expression Omnibus database for differential gene expression.
  • Performed RNA immunoprecipitation to confirm mRNA binding.

Main Results:

  • YTHDC1 inhibition reduced inflammation and improved cardiac function in an LPS-induced SIC model.
  • SERPINA3N was identified as a differentially expressed gene in SIC.
  • YTHDC1 directly binds to and regulates SERPINA3N mRNA expression.
  • SERPINA3N knockdown decreased LPS-induced inflammation in cardiac myocytes.

Conclusions:

  • The m6A reader YTHDC1 plays a crucial role in mediating inflammation in SIC by regulating SERPINA3N.
  • These findings establish a link between YTHDC1 and SIC, suggesting YTHDC1 as a potential therapeutic target.